» Articles » PMID: 27523813

Contrast-enhanced CT- and MRI-based Perfusion Assessment for Pulmonary Diseases: Basics and Clinical Applications

Overview
Date 2016 Aug 16
PMID 27523813
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Assessment of regional pulmonary perfusion as well as nodule and tumor perfusions in various pulmonary diseases are currently performed by means of nuclear medicine studies requiring radioactive macroaggregates, dual-energy computed tomography (CT), and dynamic first-pass contrast-enhanced perfusion CT techniques and unenhanced and dynamic first-pass contrast enhanced perfusion magnetic resonance imaging (MRI), as well as time-resolved three-dimensional or four-dimensional contrast-enhanced magnetic resonance angiography (MRA). Perfusion scintigraphy, single-photon emission tomography (SPECT) and SPECT fused with CT have been established as clinically available scintigraphic methods; however, they are limited by perfusion information with poor spatial resolution and other shortcomings. Although positron emission tomography with 15O water can measure absolute pulmonary perfusion, it requires a cyclotron for generation of a tracer with an extremely short half-life (2 min), and can only be performed for academic purposes. Therefore, clinicians are concentrating their efforts on the application of CT-based and MRI-based quantitative and qualitative perfusion assessment to various pulmonary diseases. This review article covers 1) the basics of dual-energy CT and dynamic first-pass contrast-enhanced perfusion CT techniques, 2) the basics of time-resolved contrast-enhanced MRA and dynamic first-pass contrast-enhanced perfusion MRI, and 3) clinical applications of contrast-enhanced CT- and MRI-based perfusion assessment for patients with pulmonary nodule, lung cancer, and pulmonary vascular diseases. We believe that these new techniques can be useful in routine clinical practice for not only thoracic oncology patients, but also patients with different pulmonary vascular diseases.

Citing Articles

Role of pulmonary perfusion magnetic resonance imaging for the diagnosis of pulmonary hypertension: A review.

Lacharie M, Villa A, Milidonis X, Hasaneen H, Chiribiri A, Benedetti G World J Radiol. 2023; 15(9):256-273.

PMID: 37823020 PMC: 10563854. DOI: 10.4329/wjr.v15.i9.256.


Area-Detector Computed Tomography for Pulmonary Functional Imaging.

Ohno Y, Ozawa Y, Nagata H, Bando S, Cong S, Takahashi T Diagnostics (Basel). 2023; 13(15).

PMID: 37568881 PMC: 10416899. DOI: 10.3390/diagnostics13152518.


Advances for Pulmonary Functional Imaging: Dual-Energy Computed Tomography for Pulmonary Functional Imaging.

Ozawa Y, Ohno Y, Nagata H, Tamokami K, Nishikimi K, Oshima Y Diagnostics (Basel). 2023; 13(13).

PMID: 37443688 PMC: 10340383. DOI: 10.3390/diagnostics13132295.


Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.

Wang F, Zhang W, Chai Y, Wang H, Liu Z, He Y Front Immunol. 2022; 13:1015436.

PMID: 36458007 PMC: 9705340. DOI: 10.3389/fimmu.2022.1015436.


Functional lung imaging in thoracic tumor radiotherapy: Application and progress.

Zhou P, Zhang S Front Oncol. 2022; 12:908345.

PMID: 36212454 PMC: 9544588. DOI: 10.3389/fonc.2022.908345.


References
1.
Ohno Y, Koyama H, Matsumoto K, Onishi Y, Nogami M, Takenaka D . Dynamic MR perfusion imaging: capability for quantitative assessment of disease extent and prediction of outcome for patients with acute pulmonary thromboembolism. J Magn Reson Imaging. 2010; 31(5):1081-90. DOI: 10.1002/jmri.22146. View

2.
Ohno Y . New applications of magnetic resonance imaging for thoracic oncology. Semin Respir Crit Care Med. 2014; 35(1):27-40. DOI: 10.1055/s-0033-1363449. View

3.
Matsuoka S, Hunsaker A, Gill R, Jacobson F, Ohno Y, Patz S . Functional MR imaging of the lung. Magn Reson Imaging Clin N Am. 2008; 16(2):275-89, ix. DOI: 10.1016/j.mric.2008.03.006. View

4.
Soler X, Kerr K, Marsh J, Renner J, Hoh C, Test V . Pilot study comparing SPECT perfusion scintigraphy with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Respirology. 2011; 17(1):180-4. DOI: 10.1111/j.1440-1843.2011.02061.x. View

5.
Miyazaki M, Akahane M . Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging. 2011; 35(1):1-19. DOI: 10.1002/jmri.22789. View